CHAD Therapeutics

CHAD Therapeutics was a prominent medical device company specializing in the development and manufacture of respiratory care products, particularly oxygen-conserving devices. The company was a pioneer in oxygen conservation technology, best known for its OXYMATIC electronic oxygen conserver, which significantly improved the efficiency and portability of oxygen therapy for patients with chronic lung diseases. Headquartered in Chatsworth, California, CHAD Therapeutics served the home healthcare market and was a leader in the transition to ambulatory oxygen therapy. The company was publicly traded on the NASDAQ under the symbol CHAD until its acquisition by Drive Medical in 2008. Its legacy continues through the integration of its technologies into the portfolios of its successors in the respiratory care industry.